Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020136282 - NOROVIRUS VACCINES

Publication Number WO/2020/136282
Publication Date 02.07.2020
International Application No. PCT/EP2019/087160
International Filing Date 30.12.2019
IPC
A61K 39/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
A61K 39/295 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
295Polyvalent viral antigens; Mixtures of viral and bacterial antigens
A61P 31/14 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
CPC
A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
A61K 39/295
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
295Polyvalent viral antigens
A61P 31/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
C12N 2770/16034
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2770ssRNA Viruses positive-sense
00011ssRNA Viruses positive-sense
16011Caliciviridae
16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applicants
  • THEMIS BIOSCIENCE GMBH [AT]/[AT]
Inventors
  • TAUBER, Erich
  • MÜLLNER, Matthias
  • RAMSAUER, Katrin
  • SCHRAUF, Sabrina
  • IRMLER, Angelika
  • CSAR, Patrick
  • MAIER, David A.
  • STRITZKER, Jochen
Agents
  • EISENFÜHR SPEISER PATENTANWÄLTE RECHTSANWÄLTE PARTGMBB
Priority Data
18248201.828.12.2018EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NOROVIRUS VACCINES
(FR) VACCINS CONTRE LE NOROVIRUS
Abstract
(EN)
The present invention provides immunogenic compositions, nucleic acid molecules and VLPs suitable as Norovirus vaccine candidates. Further provided are host cells for producing the biological material as well as methods for producing and/or purifying the immunogenic compositions and VLPs. Further provided is an immunogenic composition for use in methods of preventing/treating a Norovirus infection in a subject.
(FR)
La présente invention concerne des compositions immunogènes, des molécules d'acide nucléique et des VLP appropriées en tant que candidats de vaccin contre le norovirus. L'invention concerne en outre des cellules hôtes pour produire le matériau biologique, ainsi que des procédés de production et/ou de purification des compositions immunogènes et des VLP. L'invention concerne en outre une composition immunogène destinée à être utilisée dans des procédés de prévention/traitement d'une infection par un norovirus chez un sujet.
Also published as
Latest bibliographic data on file with the International Bureau